1-6 of 6
Oncology and Informatics
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Post-Marketing Safety of Temozolomide: A Pharmacovigilance Study Based on the Food and Drug Administration Adverse Event Reporting System

Subject Area:
Oncology
Yuhao Lin, Muling Deng, Siqi Xu, Chuanben Chen, Jianming Ding
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000542989
Published Online: 24 January 2025
View article titled, Post-Marketing Safety of Temozolomide: A Pharmacovigilance Study Based on the Food and Drug Administration Adverse Event Reporting System
Open the PDF for Post-Marketing Safety of Temozolomide: A Pharmacovigilance Study Based on the Food and Drug Administration Adverse Event Reporting System in another window
Journal Articles

Diagnostic Value of Artificial Intelligence-Based Pathology Diagnosis System in Lymphatic Metastasis of Gastric Cancer

Subject Area:
Oncology
Tiantian Zhao, Qiong Wu, Chenglou Zhu, Hong Ma, Mingxu Da
Journal: Oncology
Oncology 1–10.
https://doi.org/10.1159/000542852
Published Online: 02 December 2024
View article titled, Diagnostic Value of Artificial Intelligence-Based Pathology Diagnosis System in Lymphatic Metastasis of Gastric Cancer
Open the PDF for Diagnostic Value of Artificial Intelligence-Based Pathology Diagnosis System in Lymphatic Metastasis of Gastric Cancer in another window
Journal Articles

First-Line Durvalumab plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice

Subject Area:
Oncology
Yasutoshi Fujii, Tomokazu Kawaoka, Yuki Shirane, Ryoichi Miura, Hikaru Nakahara, Kenji Yamaoka, Shinsuke Uchikawa, Hatsue Fujino, Atsushi Ono, Eisuke Murakami, Daiki Miki, Nelson Clair Hayes, Masataka Tsuge, Yuko Nakamura, Kazuo Awai, Shiro Oka
Journal: Oncology
Oncology 1–6.
https://doi.org/10.1159/000542517
Published Online: 11 November 2024
View article titled, First-Line Durvalumab plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice
Open the PDF for First-Line Durvalumab plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice in another window
Journal Articles

Disproportionality Analysis of Stomatitis Associated with Anticancer Drugs Using the Japanese Adverse Drug Event Report Database

Subject Area:
Oncology
Kousuke Hosonaka, Kenta Yamaoka, Naoe Ikeda, Mayako Uchida, Yoshihiro Uesawa, Kazushige Takahashi, Tadashi Shimizu
Journal: Oncology
Oncology (2024) 102 (9): 810–817.
https://doi.org/10.1159/000535331
Published Online: 10 January 2024
View article titled, Disproportionality Analysis of Stomatitis Associated with Anticancer Drugs Using the Japanese Adverse Drug Event Report Database
Open the PDF for Disproportionality Analysis of Stomatitis Associated with Anticancer Drugs Using the Japanese Adverse Drug Event Report Database in another window
Journal Articles

Transarterial Chemoembolization Combined with Lenvatinib for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Subject Area:
Oncology
Xiaxia Pei, Jun Zhao, Zhiping Wang
Journal: Oncology
Oncology (2024) 102 (8): 688–702.
https://doi.org/10.1159/000536006
Published Online: 08 January 2024
View article titled, Transarterial Chemoembolization Combined with Lenvatinib for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Open the PDF for Transarterial Chemoembolization Combined with Lenvatinib for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials in another window
Journal Articles

Adverse Metabolic Effects on Glucose in Patients Receiving Anamorelin Using a Japanese Claims Database

Subject Area:
Karger e-Journal Backfile Collection 2023 , Oncology
Hiroaki Ohta, Takeshi Horii, Takeo Yasu
Journal: Oncology
Oncology (2023) 101 (12): 782–785.
https://doi.org/10.1159/000533539
Published Online: 14 August 2023
View article titled, Adverse Metabolic Effects on Glucose in Patients Receiving Anamorelin Using a Japanese Claims Database
Open the PDF for Adverse Metabolic Effects on Glucose in Patients Receiving Anamorelin Using a Japanese Claims Database in another window